eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
5/2018
vol. 35
 
Share:
Share:
more
 
 
abstract:
Original paper

Male and female genital lichen sclerosus. Clinical and functional classification criteria

Alessandra Latini, Carlo Cota, Diego Orsini, Antonio Cristaudo, Marinella Tedesco

Adv Dermatol Allergol 2018; XXXV (5): 447-453
Online publish date: 2018/07/19
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Lichen sclerosus (LS) is a chronic inflammatory disease affecting mainly the genital mucous membranes in both sexes. In the past, different terms were used to describe the disease, rendering a unique and specific clinical classification impossible.

Aim
New therapeutic approaches are being defined, which may contribute to a proper clinical management, however, a stage classification is essential to better define appropriate treatment for every stage of the disease.

Material and methods
One hundred and fifteen patients (50 women and 65 men) with a diagnosis of LS were enrolled between January 2014 and September 2016. All patients underwent cutaneous biopsy to confirm the clinical diagnosis of LS. Clinical and symptomatological parameters were used in order to put the patients into the correct stage of LS. The Dermatology Life Quality Index (DLQI) was used to classify patients based on subjective symptoms. Different cutaneous alterations and structural modifications of the genital mucosa were also taken into consideration in order to assign every patient to a specific stage.

Conclusions
Lichen sclerosus is clinically described differently in females and in males and every form of LS is put into one of two stages according to the degree of severity: early and late stages. Within the clinical practice, it is useful to screen patients for groups of early or late forms of the disease in order to obtain a uniform subdivision of patients: those who may benefit from localized treatments, require a systemic drug and must undergo physical treatments (surgical, stem cells infiltrations).

keywords:

clinical staging, classification, diagnosis,lichen sclerosus, prognosis, treatment criteria

references:
Kantere D, Lowhagen GB, Alvengren G, et al. The clinical spectrum of lichen sclerosus in male patients – a retrospective study. Acta Derm Venereol 2014; 94: 542-6.
Weir RF. Icthyosis of the tongue and vulva. NY State J Med 1875: 246.
Breisky A. Uber Kraurosis vulvae. Z Heilkr 1885; 6: 69.
Hallopeau H. Lichen plans scléreux. Ann Derm Syph (2nd series) 1889; 20: 447-9.
Darier J. Lichen plans cléreux. Ann Derm Syph 1892; 23: 833-7.
Montgomery FH, Ormsby OS. “White spot disease” (morphoea guttata) and lichen planussclerosus et atrophicus. J Cutan Dis 1907; 25: 1-16.
Csillag J. Dermatitis lichenoides chronica atrophicans. Ikonographia Dermatol 1909; 4: 147.
Stiihmer A. Balanitis xerotica obliterans (post operationem) und ihre beziehungen zur Kraurosis glandis et preaeputii Penis. Arch Derm Syph (Berlin) 1928; 156: 613- 23.
Friedrich EG. Lichen sclerosus. J Reprod Med 1976; 17: 147-54.
Friedrich EG. New nomenclature for vulvar disease. Obstet Gynecol 1976; 47: 122-4.
Leelavathy G, Parmar H, Das JK, Gangopadhyay A. Extragenital lichen sclerosus et atrophicus. Indian J Dermatol 2015; 60: 420.
Vazquez MG, Navarra R, Urda MT, et al. Lichen sclerosus et atrophicus with cutaneous distribution simulating lichen planus. Case Rep Dermatol 2010; 2: 55-9.
Virgili A, Borghi A, Toni G, et al. Prospective clinical and epidemiologic study of vulvar lichen sclerosus: analysis of prevalence and severity of clinical features, togheter with historical and demographic associations. Dermatology 2014; 228: 542-6.
Neill SM, Lewis FM, Tatnall FM, Cox NH. British Association of Dermatologist’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163: 672-82.
Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus Br J Dermatol 2002; 147: 640-9.
Carlson BC, Hofer MD, Ballek N, et al. Protein markers of malignant potential in penile and vulvar lichen sclerosus. J Urol 2013; 190: 399-406.
Goldstein AT, Marinoff SC, Christofer K. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. J Pediatr Adolesc Gynecol 2004; 17: 35-7.
Higgins CA, Cruickshank ME. A population-based case-control study of aetiological factors associated with vulvar lichen sclerosus. J Obstet Gynaecol 2012; 32: 271-5.
Alvarez-Vijande R. One-step reconstructionof penile urethral strictures. Indications and techniques. Arch Esp Urol 2014; 67: 35-45.
Ambrifi M, Dona MG, Tedesco M, et al. Lichen sclerosus in stable sexual partners: etiologic correlation or mere coincidence? G Ital Dermatol Venereol 2017; 152: 92-4.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple, practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 2010-6.
Bellei B, Migliano E, Tedesco M, et al. Maximizing non-enzymatic methods for harvesting adipose-derived stem from lipoaspirate: technical considerations and clinical implications for regenerative surgery. Sci Rep 2017; 7: 10015.
Casabona F, Priano V, Vallerino V, et al. New surgical approach to lichen sclerosus of the vulva: the role of adipose-derived mesenchymal cells and platelet-rich plasma in tissue re generation. Plastic Reconstr Surg 2010; 126: 210e-1e.
Onesti GM, Carella S, Ceccarelli S, et al. The use of human adipose-derived stem cells in the treatment of physiological and pathological vulvar dystrophies. Stem Cells Int 2016; 2016: 2561461.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe